Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weight

Urology

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Urology|February 29, 2020
A Large Renal Mass: Dilemmas With Unusual Features on ImagingSubodh K Regmi, Christopher J Weight
Urology|December 16, 2006
Single system ectopic ureter to rectum subtending solitary kidney and bladder agenesis in newborn maleChristopher J Weight, Deepa Chand, Jonathan H Ross
Urology|April 28, 2009
Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomesMatthew N Simmons, Christopher J Weight, Inderbir S Gill
Urology|April 6, 2010
Avagard hand antisepsis vs. traditional scrub in 3600 pediatric urologic proceduresChristopher J Weight, Michael C Lee, Jeffrey S Palmer
Urology|July 15, 2017
Comparative Evaluation of Bladder-specific Health-related Quality of Life Instruments for Bladder CancerTravis J Moncrief, Priya Balaji, Bruce B Lindgren, et al.
Urology|August 27, 2017
The Effects of Population-based Prostate-specific Antigen Screening Beginning at Age 40Christopher J Weight, Vikram M Narayan, Daniel Smith, et al.
Urology|March 23, 2011
Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomyChristopher J Weight, Casey Lythgoe, Raman Unnikrishnan, et al.
Urology|October 24, 2013
Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohortChristopher J Weight, Simon P Kim, Debra J Jacobson, et al.
Urology|February 5, 2008
Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancerChristopher J Weight, Alwyn M Reuther, Paul W Gunn, et al.
Urology|April 17, 2012
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosisChristopher J Weight, Simon P Kim, R Jeffrey Karnes, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Urology|February 29, 2020
A Large Renal Mass: Dilemmas With Unusual Features on ImagingSubodh K Regmi, Christopher J Weight
Urology|December 16, 2006
Single system ectopic ureter to rectum subtending solitary kidney and bladder agenesis in newborn maleChristopher J Weight, Deepa Chand, Jonathan H Ross
Urology|April 28, 2009
Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomesMatthew N Simmons, Christopher J Weight, Inderbir S Gill
Urology|April 6, 2010
Avagard hand antisepsis vs. traditional scrub in 3600 pediatric urologic proceduresChristopher J Weight, Michael C Lee, Jeffrey S Palmer
Urology|July 15, 2017
Comparative Evaluation of Bladder-specific Health-related Quality of Life Instruments for Bladder CancerTravis J Moncrief, Priya Balaji, Bruce B Lindgren, et al.
Urology|August 27, 2017
The Effects of Population-based Prostate-specific Antigen Screening Beginning at Age 40Christopher J Weight, Vikram M Narayan, Daniel Smith, et al.
Urology|March 23, 2011
Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomyChristopher J Weight, Casey Lythgoe, Raman Unnikrishnan, et al.
Urology|October 24, 2013
Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohortChristopher J Weight, Simon P Kim, Debra J Jacobson, et al.
Urology|February 5, 2008
Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancerChristopher J Weight, Alwyn M Reuther, Paul W Gunn, et al.
Urology|April 17, 2012
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosisChristopher J Weight, Simon P Kim, R Jeffrey Karnes, et al.
Pageof 3